European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)
Abstract Hereditary haemorrhagic telangiectasia (HHT) is a multisystemic vascular dysplasia inherited as an autosomal dominant trait. Approximately 10 % of patients have cerebral vascular malformations, a proportion being cerebral arteriovenous malformations (AVMs) and fistulae that may lead to pote...
Main Authors: | Omer F. Eker, Edoardo Boccardi, Ulrich Sure, Maneesh C. Patel, Saverio Alicante, Ali Alsafi, Nicola Coote, Freya Droege, Olivier Dupuis, Annette Dam Fialla, Bryony Jones, Ujwal Kariholu, Anette D. Kjeldsen, David Lefroy, Gennaro M. Lenato, Hans Jurgen Mager, Guido Manfredi, Troels H. Nielsen, Fabio Pagella, Marco C. Post, Catherine Rennie, Carlo Sabbà, Patrizia Suppressa, Pernille M. Toerring, Sara Ugolini, Elisabetta Buscarini, Sophie Dupuis-Girod, Claire L. Shovlin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Orphanet Journal of Rare Diseases |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01386-9 |
Similar Items
-
European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
by: Claire L. Shovlin, et al.
Published: (2018-08-01) -
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
by: C. L. Shovlin, et al.
Published: (2019-08-01) -
Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab
by: Fabio Pagella, et al.
Published: (2020-12-01) -
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
by: Elisabetta Buscarini, et al.
Published: (2019-02-01) -
Near-fatal haemorrhage from pulmonary arteriovenous malformation in HHT with increased cardiac output
by: V. Cottin, et al.
Published: (2009-09-01)